Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
Why Are Black Women Missing from Clinical Trials?
Research & Development Why Are Black Women Missing from Clinical Trials?

The alarming underrepresentation of Black women in clinical trials, particularly in cancer research, stands as a critical public health issue that cannot be ignored, especially given their 38% higher likelihood of dying from breast cancer compared to other groups. Despite this stark statistic,

Digital Twin Ablation Boosts Success for Atrial Fibrillation
Tech & Innovation Digital Twin Ablation Boosts Success for Atrial Fibrillation

Imagine a world where a virtual replica of a patient’s heart could predict and guide life-changing treatments with pinpoint accuracy, transforming the battle against a condition as challenging as atrial fibrillation (AF). This vision became a reality at the ESC Congress, where a groundbreaking

Digital Therapy App Tested for Knee Pain Relief in Trial
Research & Development Digital Therapy App Tested for Knee Pain Relief in Trial

In a remarkable stride toward modernizing healthcare, a clinical trial is underway to evaluate MORA Cure PFP, a cutting-edge digital therapy app designed to alleviate knee pain caused by patellofemoral pain syndrome (PFP), a condition marked by discomfort around or behind the kneecap. This ailment

Can Urine Test Revolutionize Prostate Cancer Detection?
Research & Development Can Urine Test Revolutionize Prostate Cancer Detection?

Imagine a world where a simple, noninvasive test could detect prostate cancer with pinpoint accuracy, sparing countless men from the anxiety and discomfort of unnecessary biopsies, and potentially transforming the landscape of early diagnosis. Prostate cancer remains a leading cause of

How Do New ESC Guidelines Empower Women in High-Risk Pregnancies?
Research & Development How Do New ESC Guidelines Empower Women in High-Risk Pregnancies?

What happens when the joy of expecting a child is overshadowed by the shadow of life-threatening heart conditions? For countless women with cardiovascular disease, this is not a hypothetical question but a harsh reality that they face every day. Across the globe, maternal heart disease stands as

Mini Camera and AI Detect Hidden Heart Attack Risks
Tech & Innovation Mini Camera and AI Detect Hidden Heart Attack Risks

Imagine a world where a tiny camera, no larger than a grain of rice, can peer into the depths of coronary arteries to uncover hidden dangers that could lead to a devastating heart attack, a reality now being shaped by cutting-edge technology. Recurrent heart attacks strike approximately 15% of

How Is Esaote Revolutionizing Cardiac Ultrasound at ESC 2025?
Tech & Innovation How Is Esaote Revolutionizing Cardiac Ultrasound at ESC 2025?

In the ever-evolving landscape of cardiovascular care, staying ahead of diagnostic challenges is paramount for healthcare professionals striving to improve patient outcomes across diverse clinical settings. At the European Society of Cardiology (ESC) Congress held from August 29 to September 1 at

Can Rare HIV Cures Lead to a Universal Immunotherapy?
Research & Development Can Rare HIV Cures Lead to a Universal Immunotherapy?

What if a tiny fraction of people held the key to eradicating one of humanity's most persistent viruses, offering hope to the over 38 million individuals living with HIV worldwide? This virus has defied a universal cure for decades, yet in a handful of remarkable cases, some have walked away

Can Emory's New Medicines Center Transform Drug Discovery?
Research & Development Can Emory's New Medicines Center Transform Drug Discovery?

In a world where the journey from scientific discovery to life-saving treatment often spans decades, Emory University in Atlanta, Georgia, is taking bold steps to accelerate this process with the launch of its Center for New Medicines (CNM). Established just last year, this pioneering initiative

Is Fat Distribution the True Key to Heart Aging Risks?
Tech & Innovation Is Fat Distribution the True Key to Heart Aging Risks?

Imagine a world where a simple number like body mass index (BMI) no longer dictates how heart disease risks are assessed, and instead, the focus shifts to where fat resides in the body, marking a significant change in medical perspectives. This isn’t a distant dream but a pressing reality in 2025,

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later